Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Are Opioid Contracts Helpful or Harmful?

Steven M. Harris, Esq.  |  Issue: October 2019  |  October 18, 2019

  • The risk of prescription opioid misuse is minimized;
  • The harmful effects associated with opioid use are communicated to the patient;
  • A deterrent to self-medicating and drug-seeking behavior is provided; and
  • Consistent medical care is provided, irrespective of race or financial status.

Harmful Effects

Despite the contract’s best intentions, many providers find opioid contracts do more harm than good. There is questionable evidence regarding whether the agreements actually reduce opioid misuse in patients with chronic pain. Additionally, many patients complained their stress and anxiety increased as a result of the agreement due to concerns associated with fulfilling its terms.

Some patients who claimed they had no substance abuse issues feared a mistake would lead to their urine sample testing positive for drugs it should not or testing negative for drugs for which it should test positive. These patients feared they would lose the pain medication they have come to rely on.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Further, some physicians and patients feel the agreements cause the physician–patient relationship to break down. Instead of a way to carefully navigate a complicated medical problem, the contract becomes the foundation for treatment, and if violated, the treatment abruptly ends.

Improving the Effect of Opioid Agreements

Here’s a sample of possible opioid-patient contractual provisions.

Whether a physician agrees with the use of opioid agreements or is legally obligated to enter into them under state law, certain measures can be taken to enhance the positive effect of the agreements. These measures include:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  1. Carefully drafting the agreement using plain language that is easily understood by the patient. Forcing patients to sign a document loaded with legalese can negate the whole purpose of the agreement;
  2. Taking time to calmly walk the patient through the terms of the agreement so he or she understands the expectations and is aware of all actions that could impact treatment;
  3. Periodically reviewing the terms of the agreement with each patient to confirm they continue to understand and abide by the expectations and responsibilities agreed to; and
  4. For patients violating the terms of the agreement, weaning the patients off the medication, if permitted, instead of completely cutting them off.

Steven M. Harris, Esq.Steven M. Harris, Esq., is a nationally recognized healthcare attorney with McDonald Hopkins LLC. Contact him via email at [email protected].

Page: 1 2 | Single Page
Share: 

Filed under:Legal Updates Tagged with:opioid contractsopioid crisisphysician patient relationship

Related Articles

    Speak Out Rheum: How Did We Go So Wrong with Opioid Prescribing?

    November 4, 2022

    I have been listening to The Fighter Pilot Podcast because my fantasy career would have been to fly a jet fighter plane (not even remotely possible, given my constitution). I learned that when an aircraft accident occurs, a mishap board is convened, not to assign blame but to try to learn what went wrong and…

    ah_designs / shutterstock.com

    The Perils of Pain Meds Revisited

    December 18, 2018

    More than 10 years ago, I wrote a commentary in The Rheumatologist, called “Perils of Pain Meds,” about the over-prescribing of opioid analgesics for common causes of chronic noncancer pain, which was a major contributor to the opioid epidemic.1 Since that time, although there has been a greater than 20% decrease in opioid prescribing, the…

    Rheumatologists Respond to Prescription Opioid Analgesic Crisis

    May 16, 2017

    The alarming statistics on prescription opioid overdoses are well known to medical professionals, thanks to the Centers for Disease Control and Prevention (CDC)’s widely cited finding that deaths from opioid analgesics have increased fourfold since 1999.1 Half of all fatal drug overdoses now involve opioids prescribed by a doctor. Meanwhile, a lack of rigorous research…

    10 Tips for Opioid Prescribing

    December 1, 2014

    How to manage the risks when prescribing medications for patients in chronic pain

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences